Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Effects of the inhibition of cytosolic phospholipase A(2)α in non-small cell lung cancer cells.
Sundarraj S, Kannan S, Thangam R, Gunasekaran P.
J Cancer Res Clin Oncol. 2012 May;138(5):827-35. Epub 2012 Jan 25.
Related citations
Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Qi WX, Tang LN, He AN, Shen Z, Yao Y.
J Cancer Res Clin Oncol. 2012 May;138(5):745-51. Epub 2012 Jan 19.
Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.
Hahn N, Heiden M, Seitz R, Salge-Bartels U.
J Cancer Res Clin Oncol. 2012 Apr;138(4):695-703. Epub 2012 Jan 12.
Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer.
Markova B, Hähnel PS, Kasper S, Herbertz S, Schuler M, Breitenbuecher F.
J Cancer Res Clin Oncol. 2012 Apr;138(4):545-54. Epub 2011 Dec 28.
A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer.
Cheng J, Ha M, Wang Y, Sun J, Chen J, Wang Y, Tong C.
J Cancer Res Clin Oncol. 2012 Feb;138(2):231-8. Epub 2011 Nov 20.
NS398 induces apoptosis in non-small cell lung cancer cells.
Qiu R, Chen J, Sima J, Shen X, Liu D, Shen J.
J Cancer Res Clin Oncol. 2012 Jan;138(1):119-24. Epub 2011 Nov 3.
A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR.
Lin Q, Mao W, Shu Y, Lin F, Liu S, Shen H, Gao W, Li S, Shen D.
J Cancer Res Clin Oncol. 2012 Jan;138(1):85-93. Epub 2011 Oct 19.
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome.
Falkenstern-Ge RF, Kimmich M, Friedel G, Tannapfel A, Neumann V, Kohlhaeufl M.
J Cancer Res Clin Oncol. 2011 Oct;137(10):1495-8. Epub 2011 Aug 9.
Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer.
Morita R, Sato K, Nakano M, Miura H, Odaka H, Nobori K, Kosaka T, Sano M, Watanabe H, Shioya T, Ito H.
J Cancer Res Clin Oncol. 2011 Dec;137(12):1849-57. Epub 2011 Sep 17.
Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis.
Xu YJ, Shao YF, Zhao X, Geng YT, Wang K, Yin YM.
J Cancer Res Clin Oncol. 2011 Dec;137(12):1841-8. Epub 2011 Sep 17.
The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer.
Zhang S, Zheng Y, Yu P, Yu F, Zhang Q, Lv Y, Xie X, Gao Y.
J Cancer Res Clin Oncol. 2011 Dec;137(12):1813-22. Epub 2011 Sep 16.
Solute carrier protein family may involve in radiation-induced radioresistance of non-small cell lung cancer.
Xie L, Song X, Yu J, Guo W, Wei L, Liu Y, Wang X.
J Cancer Res Clin Oncol. 2011 Dec;137(12):1739-47. Epub 2011 Sep 10.
Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway.
Liu D, Huang Y, Zeng J, Chen B, Huang N, Guo N, Liu L, Xu H, Mo X, Li W.
J Cancer Res Clin Oncol. 2011 Nov;137(11):1629-40. Epub 2011 Aug 23.
Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer.
Umemura S, Yamane H, Suwaki T, Katoh T, Yano T, Shiote Y, Takigawa N, Kiura K, Kamei H.
J Cancer Res Clin Oncol. 2011 Oct;137(10):1469-75. Epub 2011 Aug 5.
Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro.
Ulukaya E, Ari F, Dimas K, Sarimahmut M, Guney E, Sakellaridis N, Yilmaz VT.
J Cancer Res Clin Oncol. 2011 Oct;137(10):1425-34. Epub 2011 Aug 2.
Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
Sun YF, Yang XR, Zhou J, Qiu SJ, Fan J, Xu Y.
J Cancer Res Clin Oncol. 2011 Aug;137(8):1151-73. Epub 2011 Jun 17. Review.
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy.
Lee S, Kim Y, Sun JM, Choi YL, Kim JG, Shim YM, Park YH, Ahn JS, Park K, Han JH, Ahn MJ.
J Cancer Res Clin Oncol. 2011 Aug;137(8):1203-11. Epub 2011 May 28.
Synergistic interaction between sunitinib and docetaxel is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation.
Pan F, Tian J, Zhang X, Zhang Y, Pan Y.
J Cancer Res Clin Oncol. 2011 Sep;137(9):1397-408. Epub 2011 Jul 28.
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial.
Butts C, Maksymiuk A, Goss G, Soulières D, Marshall E, Cormier Y, Ellis PM, Price A, Sawhney R, Beier F, Falk M, Murray N.
J Cancer Res Clin Oncol. 2011 Sep;137(9):1337-42. Epub 2011 Jul 9.
Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort.
Müller CB, de Barros RL, Castro MA, Lopes FM, Meurer RT, Roehe A, Mazzini G, Ulbrich-Kulczynski JM, Dal-Pizzol F, Fernandes MC, Moreira JC, Xavier LL, Klamt F.
J Cancer Res Clin Oncol. 2011 Sep;137(9):1309-16. Epub 2011 Jul 8.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on